Psoriasis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin D Analogues, Corticosteroids, Others), By Route of Administration (Parenteral, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 19, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. North America Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  8. Europe Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  9. APAC Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  11. LATAM Psoriasis Treatment Market Size Analysis
    1. Introduction
    2. Psoriasis Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Tumor Necrosis Factor Inhibitors
      2. Interleukin Inhibitors
      3. Vitamin D Analogues
      4. Corticosteroids
      5. Others
    3. Psoriasis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Parenteral
      2. Oral
      3. Topical
    4. Psoriasis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Psoriasis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson
    3. Novartis AG
    4. Eli Lilly and Company
    5. Amgen Inc.
    6. Pfizer Inc.
    7. Bristol Myers Squibb
    8. Sobi
    9. LEO Pharma A/S
    10. Merck & Co., Inc.
    11. Boehringer Ingelheim
    12. AstraZeneca
    13. Biogen Inc.
    14. Takeda Pharmaceutical Company Limited
    15. Sun Pharmaceutical Industries Ltd.
    16. GlaxoSmithKline plc
    17. Sanofi
    18. Celgene Corporation
    19. Biocon Limited
    20. Glenmark Pharmaceuticals
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: